{
  "docId": "019dd923-622b-71dc-a6d9-fc4318e06f9b",
  "docSlug": "6ded4b1cfe2c",
  "documentTitle": "Bristol-Myers Squibb Company (BMY)",
  "authorId": "03_Starboard_Value",
  "authorName": "Starboard Value",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2019-03-18 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 48,
  "pageCount": 197,
  "prevPage": 47,
  "nextPage": 49,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 6,
  "notes": "Includes a screenshot of a BMS slide and a bar chart of sales estimates.",
  "elementsJson": [
    "headline_text",
    "subtitle_text",
    "screenshot",
    "bar_chart_vertical",
    "quote_block"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622b-71dc-a6d9-fc4318e06f9b/48",
  "deckHref": "/decks/019dd923-622b-71dc-a6d9-fc4318e06f9b",
  "deckJsonHref": "/decks/019dd923-622b-71dc-a6d9-fc4318e06f9b.json",
  "deckAnchorHref": "/decks/019dd923-622b-71dc-a6d9-fc4318e06f9b#slide-48",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "We believe OPDIVO remains a highly valuable franchise in a segment with strong secular tailwinds",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-0937-7729-87a9-94adc52c784b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.42,
        "w": 0.46,
        "x": 0.51,
        "y": 0.24
      },
      "kind": "chart",
      "text": "Wall Street Consensus - OPDIVO Sales Estimates",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "edd745fc-7156-4e4e-b79d-458d8a74f185",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.42,
        "w": 0.46,
        "x": 0.03,
        "y": 0.24
      },
      "kind": "image",
      "text": "Bristol-Myers Transaction Update - March 6, 2019",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b6b02be5-2cf9-4105-ba5b-48652c46c0b2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Opdivo Sales: $10.2",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd953-0937-7729-87a9-9cfa75b9f8af",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.92,
        "x": 0.04,
        "y": 0.13
      },
      "kind": "paragraph",
      "text": "OPDIVO is a market leader in immuno-oncology; however, we believe the tremendous franchise has been poorly managed.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "60895c02-548f-49b5-9ad1-1db4ea42d903",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.46,
        "x": 0.51,
        "y": 0.71
      },
      "kind": "quote",
      "text": "\"...we see the market's current outlook for Opdivo as overly bearish given the size of the PD-1 market...\" JP Morgan, December 2018",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8f2b0333-7673-48af-871e-40ae23c66be1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.46,
        "x": 0.03,
        "y": 0.71
      },
      "kind": "quote",
      "text": "\"...BMY is still a formidable player in IO given Opdivo's strong position in several tumors.\" Cowen, January 2019",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e5916af4-bc1b-43ca-b5f1-37bdaaa8fa61",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“…BMY is still a formidable player in IO given Opdivo’s strong position in several tumors.” — Cowen, January 2019; “…we see the market’s current outlook for Opdivo as overly bearish given the size of the PD-1 market…” — JP Morgan, December 2018",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-0937-7729-87a9-9943aa7d1369",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.25,
        "x": 0.01,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "Source: Public company filings, Wall Street research, Bloomberg.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "96b4348b-ec8e-4e3a-b7cc-218e7d45adad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.92,
        "x": 0.04,
        "y": 0.88
      },
      "kind": "title",
      "text": "We believe OPDIVO remains a highly valuable franchise in a segment with strong secular tailwinds",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e746ad76-d736-42cd-9d86-5f7c93106727",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.85,
        "x": 0.04,
        "y": 0.03
      },
      "kind": "title",
      "text": "However, OPDIVO Remains a Stable and Growing Franchise With a Strong Market Leadership Position",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb193827-f7b5-48af-b39b-4a6139f0eebd",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}